The future of cell and gene therapy manufacturing
As more cell and gene therapy products get approved to treat common conditions, scaling them up will be a challenge.

As more cell and gene therapy products get approved to treat common conditions, scaling them up will be a challenge.
MSD is one of many pharma companies migrating IT applications to the cloud to transform value chains and harness new technologies.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Japan grants approval for CSL and Arcturus’ Covid-19 vaccine
Boehringer to leverage IBM’s technologies for antibody discovery
Japan approves Daiichi Sankyo’s Covid-19 booster vaccine
IGC Pharma signs agreement to adopt AI solutions into drug discovery